NexImmune Balance Sheet Health
Financial Health criteria checks 4/6
NexImmune has a total shareholder equity of $8.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $14.6M and $6.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$9.00m |
Equity | US$8.25m |
Total liabilities | US$6.31m |
Total assets | US$14.56m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7370's short term assets ($10.3M) exceed its short term liabilities ($6.2M).
Long Term Liabilities: 7370's short term assets ($10.3M) exceed its long term liabilities ($102.8K).
Debt to Equity History and Analysis
Debt Level: 7370 is debt free.
Reducing Debt: 7370 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7370 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 7370 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.1% each year